Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick J Morrison

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Medrxiv : the Preprint Server for Health Sciences|March 18, 2026
Familial medullary thyroid carcinoma secondary to an <i>SLC30A9</i> intragenic deletion and translation reinitiationDonato Iacovazzo, Federica Begalli, Oniz Suleyman, et al.
Nature|December 18, 2012
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancerElise Ruark, Katie Snape, Peter Humburg, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 studyFergus J Couch, Olga Sinilnikova, Robert A Vierkant, et al.
Human Genetics|May 21, 2011
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriersKate M Im, Tomas Kirchhoff, Xianshu Wang, et al.
Breast Cancer Research : BCR|April 7, 2011
Exploring the link between MORF4L1 and risk of breast cancerGriselda Martrat, Christopher M Maxwell, Emiko Tominaga, et al.
Journal of the National Cancer Institute|December 21, 2010
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriersSusan J Ramus, Christiana Kartsonaki, Simon A Gayther, et al.
Journal of the National Cancer Institute|October 13, 2018
Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization StudyFrank Qian, Shengfeng Wang, Jonathan Mitchell, et al.
Journal of the National Cancer Institute|July 28, 2021
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk ScoresDaniel R Barnes, Valentina Silvestri, Goska Leslie, et al.
Hereditary Cancer in Clinical Practice|October 1, 2022
Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortiumPål Møller, Toni Seppälä, James G Dowty, et al.
Cancer Research|December 2, 2010
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk predictionAntonis C Antoniou, Jonathan Beesley, Lesley McGuffog, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Medrxiv : the Preprint Server for Health Sciences|March 18, 2026
Familial medullary thyroid carcinoma secondary to an <i>SLC30A9</i> intragenic deletion and translation reinitiationDonato Iacovazzo, Federica Begalli, Oniz Suleyman, et al.
Nature|December 18, 2012
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancerElise Ruark, Katie Snape, Peter Humburg, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 studyFergus J Couch, Olga Sinilnikova, Robert A Vierkant, et al.
Human Genetics|May 21, 2011
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriersKate M Im, Tomas Kirchhoff, Xianshu Wang, et al.
Breast Cancer Research : BCR|April 7, 2011
Exploring the link between MORF4L1 and risk of breast cancerGriselda Martrat, Christopher M Maxwell, Emiko Tominaga, et al.
Journal of the National Cancer Institute|December 21, 2010
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriersSusan J Ramus, Christiana Kartsonaki, Simon A Gayther, et al.
Journal of the National Cancer Institute|October 13, 2018
Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization StudyFrank Qian, Shengfeng Wang, Jonathan Mitchell, et al.
Journal of the National Cancer Institute|July 28, 2021
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk ScoresDaniel R Barnes, Valentina Silvestri, Goska Leslie, et al.
Hereditary Cancer in Clinical Practice|October 1, 2022
Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortiumPål Møller, Toni Seppälä, James G Dowty, et al.
Cancer Research|December 2, 2010
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk predictionAntonis C Antoniou, Jonathan Beesley, Lesley McGuffog, et al.
Pageof 16